News

T-Therapeutics appoints Dr David Hung as Chairman

T-Therapeutics appoints Dr David Hung as Chairman

Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development of the company’s pipeline of TCR-based immuno-oncology drugs

12 June 2024; Cambridge, England – T-Therapeutics, a biotechnology company developing next-generation soluble TCR therapeutics targeting cancer and autoimmune indications, today announces the appointment of biopharma industry veteran Dr David Hung as Chairman of its Board of Directors.

Discovery Park partners with Canterbury Christ Church University to open CoLab, a new coworking labspace for early stage life science businesses

New space recognises the need for more cost-effective bench space and flexible agreements for startups and spinouts

Sandwich, Kent, UK / 10th June 2024 / Discovery Park, Kent’s thriving life science community, has opened the doors to CoLab, a new shared lab facility. In partnership with Canterbury Christ Church University, CoLab has been specially designed for early-stage life science businesses, providing flexible bench space in a collaborative coworking environment.

SpeedREAD™ Service

Your Local Laboratory For Rapid Whole Plasmid Nanopore Sequencing Results

Located in Cambridge, Source Genomics is a leading provider of genomic services, processing all samples within our UK laboratory. With the introduction of our new SpeedREAD™ data delivery system for Whole Plasmid Nanopore Sequencing, we now offer unrivaled turnaround times.

Why Choose SpeedREAD™?

PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim

Milestone payment follows successful target identification and validation in separate project under same collaboration

Cambridge, UK, 03 June 2024: PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim’s ambition to develop first-in-class therapies, to transform patients’ lives.

DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation

CAMBRIDGE and NEWCASTLE, UK, 03 June 2024: DefiniGEN Ltd., and Atelerix Ltd., today announced they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US. The agreement between the companies combines DefiniGEN’s mechanistically relevant iPSC hepatocytes (Opti-Heps) with Atelerix's hydrogel preservation technology, which prevents loss of function and enables even sensitive samples to remain stable at ambient temperatures for up to two weeks.

Sparking change for women’s health: 11 promising femtech start-ups descend on Discovery Park, kicking off 2024 business support programme

The Femtech & Women’s Health edition of ‘Discovery Spark’ champions early stage businesses working to close the gender health gap

Sandwich, Kent, UK / 30^th May 2024 / Discovery Park, Kent’s thriving life science and innovation community, announced the selection of 11 promising start-ups in FemTech & Women’s Health to join Discovery Spark, their growth and support programme for early stage businesses.

June eNews

Read June's eNews

Chesterford Research Park appoints Glencar to continue construction of 60,000 sq ft Sidney Sussex Building

Three-storey, multi-occupancy building on track to provide fully fitted laboratory suites for fast-growing life science community within the Cambridge cluster

Bruntwood SciTech Launches All New Life Science Accelerator At Alderley Park, Supporting Emerging Ventures And Driving Innovation In The North West

Bruntwood SciTech is announcing the launch of its new Life Science Accelerator programme at Alderley Park in a move aimed at supporting even greater innovation and economic growth in the region.

Accelerate@Babraham selects its next set of science superstars!

Cambridge, 30^th May 2024: Six life science start-ups looking to develop products and services to make a positive difference to healthcare have been selected for one of Europe’s top incubators based at the Babraham Research Campus in Cambridge – Accelerate@Babraham.

My Account